Literature DB >> 24849647

Two cases of acute myelitis with idiopathic hypereosinophilic syndrome.

Rie Tohge1, Yoko Warabi2, Makio Takahashi3, Masahiro Nagao2.   

Abstract

Idiopathic hypereosinophilic syndrome (IHES) is characterised by persistent eosinophilia and organ damage after ruling out other causes. IHES is clinically and pathologically heterogeneous, and several disease mechanisms have been described. Although neurological involvement with IHES is extremely rare, we report the first cases of acute myelitis with IHES, which are confirmed using MRI, fulfil the diagnostic criteria of IHES and pathologically reveal eosinophilic tissue infiltration in the liver and skin. Patient 1 had longitudinally extensive transverse myelitis, which developed in the absence of steroid therapy. Patient 2 developed acute myelitis with two short lesions during a 3 mg/day corticosteroid treatment. Both cases had eosinophilia (>1500/mm(3)) at the onset of myelitis. These findings suggest that earlier treatment and a sufficient dose of corticosteroids may prevent the lesional expansion in acute myelitis. Steroid therapy should be initiated early before organ involvement, because permanent neuronal damage with a larger lesion becomes more critical. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24849647      PMCID: PMC4039971          DOI: 10.1136/bcr-2014-204326

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

Review 1.  The idiopathic hypereosinophilic syndrome.

Authors:  P F Weller; G J Bubley
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

2.  [Case of recurrent encephalomyelitis associated with eosinophilia in CSF].

Authors:  Jun Suzuki; Naoto Sugeno; Shuhei Nishiyama; Kimihiko Kaneko; Tatsuro Misu; Maki Tateyama; Toshiki Endo; Masashi Aoki
Journal:  Rinsho Shinkeigaku       Date:  2012

3.  Eosinophil-induced neurotoxicity: the role of eosinophil cationic protein/RNase 3.

Authors:  Susanna Navarro; Ester Boix; Claudi M Cuchillo; M Victòria Nogués
Journal:  J Neuroimmunol       Date:  2010-10-08       Impact factor: 3.478

4.  Natural history of severe eosinophilia with uncertain aetiology and proposals on a practical approach to its management.

Authors:  A L Ang; R X Wong; Q Y Zhuang; Y C Linn
Journal:  Intern Med J       Date:  2012-08       Impact factor: 2.048

5.  Plasma eosinophil cationic protein, interleukin-5, and ECP/Eo count ratio in patients with various eosinophilic diseases.

Authors:  Yeon-Joon Park; Eun-Jee Oh; Jong-Won Park; Myungshin Kim; Kyungja Han
Journal:  Ann Clin Lab Sci       Date:  2006       Impact factor: 1.256

Review 6.  Eosinophilic hepatic necrosis in hypereosinophilic syndrome.

Authors:  K A Ung; H Remotti; R Olsson
Journal:  J Clin Gastroenterol       Date:  2000-12       Impact factor: 3.062

7.  Spontaneous remission of a massive CNS inflammation with eosinophilic infiltrate.

Authors:  Yoshiko Tamaru; Mayumi Nakashita; Hidefumi Ito; Ryosuke Okumura; Sadayuki Matsumoto; Terukuni Imai
Journal:  Intern Med       Date:  2003-05       Impact factor: 1.271

8.  Rat eosinophil-mediated antibody-dependent cellular cytotoxicity: investigations of the mechanisms of target cell lysis and inhibition by glucocorticoids.

Authors:  C Hallam; D I Pritchard; S Trigg; R P Eady
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Transverse myelitis and polyneuropathy in idiopathic hypereosinophilic syndrome.

Authors:  C P Tsai; H H Yeh; J J Tsai; K P Lin; Z A Wu
Journal:  Muscle Nerve       Date:  1993-01       Impact factor: 3.217

Review 10.  The hypereosinophilic syndromes: current concepts and treatments.

Authors:  Gerald J Gleich; Kristin M Leiferman
Journal:  Br J Haematol       Date:  2009-05       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.